drugset / Trial / NCT03980496

Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding

NCT03980496

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to identify the best method of omeprazole (OME) application with respect to intragastric pH, cytochrome P450 2C19 (CYP2C19) genotype and phenotype.

Timeline

Start
2010-09-09
Primary completion
2013-06-08
Completion
2013-06-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 8 mg Intravenous
Comparator Omeprazole Other / unclassified 40 mg Intravenous

Indications

No indication recorded.